Cardiol Therapeutics Inc.
CRDL.TO
Price:
$3
Market Cap:
$209.65M
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce cardiovascular and respiratory events in patients hospitalized with COVID-19, as well as to evaluate the efficacy and safety of CardiolRx in acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation i...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-12-20
Stock Exchange
TSX
Ticker
CRDL.TO
The Enterprise Value as of September 2024 (TTM) for Cardiol Therapeutics Inc. (CRDL.TO) is 185.79M
According to Cardiol Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 185.79M. This represents a change of 92.65% compared to the average of 96.44M of the last 4 quarters.
Cardiol Therapeutics Inc. (CRDL.TO) Historical Enterprise Value (quarterly & annually)
How has CRDL.TO Enterprise Value performed in the past?
The mean historical Enterprise Value of Cardiol Therapeutics Inc. over the last ten years is 51.65M. The current 185.79M Enterprise Value has changed 35.87% with respect to the historical average. Over the past ten years (40 quarters), CRDL.TO's Enterprise Value was at its highest in in the September 2021 quarter at 196.82M. The Enterprise Value was at its lowest in in the December 2022 quarter at -15207647.16.
Average
51.65M
Median
51.95M
Minimum
-16267869.42
Maximum
111.50M
Cardiol Therapeutics Inc. (CRDL.TO) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of Cardiol Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 114.64%
Maximum Annual Enterprise Value = 111.50M
Minimum Annual Increase = -322.61%
Minimum Annual Enterprise Value = -16267869.42
| Year | Enterprise Value | Change |
|---|---|---|
| 2023 | 36.21M | -322.61% |
| 2022 | -16267869.42 | -196.10% |
| 2021 | 16.93M | -75.51% |
| 2020 | 69.13M | -38.00% |
| 2019 | 111.50M | 114.64% |
| 2018 | 51.95M | -43.59% |
Cardiol Therapeutics Inc. (CRDL.TO) Average Enterprise Value
How has CRDL.TO Enterprise Value performed in the past?
The current Enterprise Value of Cardiol Therapeutics Inc. (CRDL.TO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
12.29M
5-year avg
43.50M
10-year avg
51.65M
Cardiol Therapeutics Inc. (CRDL.TO) Enterprise Value vs. Peers
How is CRDL.TO’s Enterprise Value compared to its peers?
Cardiol Therapeutics Inc.’s Enterprise Value is greater than MediPharm Labs Corp. (15.59M), greater than Avicanna Inc. (41.70M), greater than Medicenna Therapeutics Corp. (124.11M), greater than Charlotte's Web Holdings, Inc. (49.82M), greater than PharmaCielo Ltd. (39.62M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 15.59M | $28.77M | |
| 41.70M | $40.62M | |
| 124.11M | $159.74M | |
| 49.82M | $29.92M | |
| 39.62M | $19.52M |
Build a custom stock screener for Cardiol Therapeutics Inc. (CRDL.TO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cardiol Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Cardiol Therapeutics Inc. (CRDL.TO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Cardiol Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cardiol Therapeutics Inc.'s Enterprise Value?
What is the highest Enterprise Value for Cardiol Therapeutics Inc. (CRDL.TO)?
What is the 3-year average Enterprise Value for Cardiol Therapeutics Inc. (CRDL.TO)?
What is the 5-year average Enterprise Value for Cardiol Therapeutics Inc. (CRDL.TO)?
How does the current Enterprise Value for Cardiol Therapeutics Inc. (CRDL.TO) compare to its historical average?